Assay development in the drug discovery process is a time intensive process. A major bottleneck within drug discovery is that various steps of the workflow are manual and disjointed. This includes the manual handling of reagents, the back-end data acquisition, as well as analysis and visualization. This means the entire process may be prone to error due to manual intervention and multiple software used for planning and analysis.

Revvity has flipped the paradigm and developed an assay development workstation which acts as a single solution for protein-protein interaction (PPI) assay development. The JANUS® G3 Assay Development workstation combines Revvity Signals VitroVivo software, JANUS® liquid handling, and the VICTOR® Nivo™ Plate Reader to create an automated iterative design process for PPI assay development. This fully integrated solution requires zero programming knowledge and reduces the risk associated with assay development using a thorough systematic approach.

Key benefits:

• Streamlined workflows for efficient assay development.
• Customizable solutions for bioanalytical assays.
• High-throughput screening for rapid analysis.
• Support for a wide range of scientific applications.